As a global powerhouse in the animal health sector, Alivira Animal Health Limited boasts a significant global presence, marked by its operations in over 100 countries. The company has a solid vision to optimize animal health and well-being and is focused on producing Active Pharmaceutical Ingredients (API) and Finished Dosage Formulations (FDF). With eight manufacturing facilities strategically located in India, Spain, Germany, Brazil, and Turkey, Alivira ensures the timely and efficient supply of high-quality products that adhere to stringent international standards set by regulatory bodies such as the US FDA, EUGMP and WHO.
As a global leader in the production of Anthelmintic APIs and the foremost provider of Veterinary APIs in India, Alivira delivers an array of health solutions for a wide range of animal species through its robust and varied product portfolio. Thus, Alivira stands as a beacon of innovation and quality in animal health, continually transforming the landscape of animal care with its state-of-the-art products and services.
Global Reach and Regulatory Approvals
Alivira Animal Health Limited has established an expansive global footprint, with significant operations across five countries: India, Spain, Germany, Brazil, and Turkey. These strategic locations ensure a smooth supply chain, with each manufacturing facility designed for optimal production and distribution efficiencies.
Alivira is India’s leading producer of Veterinary APIs, boasting cutting-edge technology and infrastructure that uphold the highest international standards. The Indian operations are crucial in producing Alivira’s robust product portfolio.
Alivira’s manufacturing facility in Spain is well-equipped to produce Finished Dosage Formulations (FDFs), contributing significantly to the company’s European market share.
The Alivira facility produces APIs and FDFs in Germany, emphasizing stringent quality controls that align with German precision and efficiency.
The Brazil operation represents Alivira’s strategic foray into South America. It plays a vital role in the company’s expansion plans, offering animal health products tailored to local needs.
In Turkey, Alivira’s manufacturing facility is specially designed to efficiently produce Anthelmintic APIs, complementing the company’s global API production capabilities.
Receiving approvals from top global regulatory bodies is a testament to Alivira’s commitment to quality. It holds approvals from the United States Food and Drug Administration (USFDA), European Union Good Manufacturing Practice (EUGMP), World Health Organization (WHO), and Therapeutic Goods Administration (TGA), reinforcing its credibility as a trusted global animal health company. The regulatory approvals vouch for the company’s adherence to rigorous quality standards, enhancing its global acceptability and stakeholder trust. These accolades reflect Alivira’s unwavering commitment to excellence in animal health and well-being.
Product Portfolio
Alivira’s product portfolio is as diverse as it is comprehensive and tailored to address the health needs of various animal species. A significant feature of this portfolio is its expertise in Anthelmintic and Veterinary APIs.
Anthelmintic APIs: Alivira is the world’s largest producer of Anthelmintic APIs, compounds used to treat a range of parasitic worm infestations in animals. These APIs form the backbone of many deworming medications, ensuring the health and vitality of livestock, pets, and other animals.
Veterinary APIs: As India’s leading producer of Veterinary APIs, Alivira plays a pivotal role in the global animal health industry. These APIs are essential in producing a wide array of veterinary medicines, contributing to preventing and treating diseases across an extensive range of animal species.
Alivira can maintain its position at the forefront of innovation in these areas by continually investing in research and development. The company’s robust portfolio extends beyond these critical areas, demonstrating a commitment to addressing various animal health concerns. As such, Alivira’s product portfolio stands as a testament to their dedication to enhancing animal well-being and health on a global scale.
Research and Development
Central to Alivira’s mission of transforming animal health is its unwavering commitment to Research and Development (R&D). This facility is staffed by highly skilled scientific professionals dedicated to developing and enhancing Alivira’s product portfolio.
In Vizag, we leverage advanced technology to pave the way for the development of innovative Active Pharmaceutical Ingredients (APIs) and Finished Dosage Formulations (FDFs). This focus on innovation is coupled with rigorous testing and quality assurance processes to ensure the safety, efficacy, and quality of Alivira’s offerings.
Alivira’s R&D efforts significantly impact the future of animal health by addressing emerging health concerns and advancing treatment methodologies. By staying at the forefront of scientific research, Alivira is enhancing the health and well-being of animals and responding proactively to the evolving needs of the global animal health sector. Consequently, Alivira’s R&D commitment underscores its role as a global leader in the animal health industry.
Farmer and Feed Mill Partnerships
Alivira has established critical partnerships with farmers and feed mill owners worldwide, working collaboratively to optimize poultry health and productivity. As a trusted partner, Alivira provides comprehensive technical services, assisting farmers in understanding and implementing best practices for poultry health management.
In doing so, Alivira leverages its R&D-driven product portfolio, including medications, vaccines, and feed additives, to address various health concerns. Alivira products are meticulously formulated to address existing health concerns, and it is ideal for staving off diseases, promoting growth, and augmenting overall poultry productivity.
The impact of Alivira’s product portfolio and technical services on poultry health and productivity is palpable. Farmers report healthier flocks and more efficient operations due to Alivira’s products and guidance. Similarly, feed mill owners find that incorporating Alivira’s feed additives into their products yields better growth rates and healthier livestock, enhancing their product quality and reputation in the market.
Alivira is playing an active role in improving poultry health and productivity by partnering with farmers and feed mill owners. This drives global food security and sustainability while reinforcing Alivira’s commitment to advancing animal health and welfare. These partnerships truly exemplify Alivira’s “Caring for Life” philosophy, underscoring their dedication to creating a healthier world for animals and people alike.
Role in Transforming Poultry Health
Alivira’s substantial contribution to global poultry health is evidenced by its targeted and holistic approach to animal health management. Underpinned by its extensive research and development, Alivira’s innovative product portfolio comprises medications, vaccines, and feed additives designed to address the unique health challenges poultry species face.
The company’s anthelmintic and veterinary APIs have revolutionized treating and preventing parasitic infections and diseases. These compounds, forming the backbone of many poultry medications, have considerably improved poultry survival rates. Notably, the anthelmintic APIs have been exceptionally effective in the global fight against parasitic worm infestations in poultry, contributing to healthier flocks and increased productivity.
Alivira’s farmer and feed mill partnerships are equally transformative. The company’s technical services have empowered farmers and feed mill owners with the knowledge and confidence to implement best practices in poultry health management. Through these collaborations, Alivira’s medications, vaccines, and feed additives have become integral to poultry health regimes globally, leading to better growth rates and overall poultry health.
Furthermore, Alivira’s proactive approach to disease prevention, instead of merely treating existing health issues, is shifting the paradigm in poultry health management. This preventative approach, coupled with the company’s relentless commitment to R&D, is driving the creation of more robust, disease-resistant poultry populations.
In summary, Alivira’s strategies and initiatives, grounded in scientific research and collaboration, have profoundly impacted poultry health. The company’s ongoing efforts, centred on producing high-quality, innovative health products and empowering partnerships, ensure their continuous pivotal role in transforming global poultry health.
In conclusion, Alivira’s global operations exemplify the harnessing of innovation and collaboration in advancing animal health. Its commitment to Research and Development, reflected in the state-of-the-art facility at Vizag, India, facilitates the creation of pioneering solutions through robust APIs, FDFs, and preventive measures. These solutions mitigate existing health issues and proactively prevent potential diseases, marking a significant shift in the traditional approach to animal health management. Alivira’s partnerships with farmers and feed mill owners worldwide epitomize the company’s collaborative approach, fostering the adoption of best practices in poultry health management. As a result, healthier and more productive poultry populations are fostered, contributing to global food security and sustainability. Looking ahead, Alivira’s innovative and research-driven approach positions it as a potent force in shaping the future of the animal health industry. With a relentless pursuit of excellence and a deep-seated commitment to the welfare of life, Alivira is set to continue making significant strides in transforming animal health on a global scale.
